
Results
9
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
9 companies
PharmaResearch
Market Cap: ₩5.0t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩477,000.00
7D
6.5%
1Y
138.5%
Oscotec
Market Cap: ₩2.1t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩54,300.00
7D
3.8%
1Y
122.1%
ALTEOGEN
Market Cap: ₩29.8t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩557,000.00
7D
1.5%
1Y
60.8%
3billion
Market Cap: ₩380.7b
Develops technology for rare disease drug discovery using bioinformatics and machine learning technology.
A394800
₩12,000.00
7D
10.9%
1Y
207.7%
Macrogen
Market Cap: ₩167.5b
Provides precision medicine and bio-engineering healthcare services in Korea and internationally.
A038290
₩15,450.00
7D
-0.2%
1Y
-4.6%
AprilBioLtd
Market Cap: ₩900.2b
AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics.
A397030
₩39,200.00
7D
2.8%
1Y
141.1%
Seegene
Market Cap: ₩1.2t
Manufactures and sells molecular diagnostics products worldwide.
A096530
₩25,000.00
7D
-2.7%
1Y
9.6%
Medy-Tox
Market Cap: ₩870.4b
Operates as a biopharmaceutical company in South Korea.
A086900
₩124,000.00
7D
-2.7%
1Y
-2.5%
ABL Bio
Market Cap: ₩9.8t
A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.
A298380
₩177,300.00
7D
8.4%
1Y
541.2%